Qing Xi Ooi supports clients with hands-on analysis and strategic advice

Viviana Moroso brings scientific depth to quality control

Siv Jönsson develops Pharmetheus’s learning agenda
Events
News

Contact us

Home
Publications

Publications

Below we provide links to posters, white papers and scientific publications by Pharmetheus affiliates in chronological order. Please note that access to some publications may require a subscription.

Search publications

Publications

02.06.26

Rock and roll – deliverables driven by standardized data specifications [2]

Program strategies and efficiencies

Automation

PAGE 34 (2026) Abstr 12091

Freiberga S, Hellner J, Etté G, Gaby A, Prusis P, Suddapalli M

08.05.26

Integrating in silico epitope prediction and mechanistic QSP modeling for benchmarking immunogenicity risk

QSP

Immunology

Methodology

QSPC 2026, Poster 21

Selvaggio G, Roeder G, Sjögren E, Johnsson E, Eriksson J.

01.05.26

The visual predictive check and real-world data

MIDD

Pharmacometrics

Methodology

Clin Pharmacol Ther. 2026 May 1. Online ahead of print.

Jasmine H, Hughes JH, Bergstrand M, Keizer RJ

28.04.26

Population pharmacokinetics and pharmacokinetics-pharmacodynamics analyses of elafibranor to support dose selection in primary biliary cholangitis

MIDD

Immunology

Regulatory interactions

Pharmacometrics

Gastroenterology

CPT Pharmacometrics Syst Pharmacol. 2026 May;15(5):e70247.

Ooi QX, Brendel K, van Beek S, Zdovc JA, Bardol M, Dehez M

24.04.26

Food effect prediction of a high permeability/low solubility drug formulated as an amorphous solid dispersion (ASD) using an Open Systems Pharmacology (OSP) PBBM approach

Phase I

PBPK & PBBM

Trial design and analysis

Methodology

PBPK Conference 2026, Oral

Vrenken P

23.04.26

PBPK modeling of subcutaneous absorption for monoclonal antibodies

PBPK & PBBM

Methodology

PBPK Conference 2026, Oral

Sjögren E

22.04.26

Open-source PBPK modeling of artemether for pediatric extrapolations: integrating enzyme ontogeny, CYP2B6 auto-induction and malnutrition

PBPK & PBBM

Specific populations

Infectious Diseases

PBPK Conference 2026, Poster 79

Eriksson J, Sjögren E

22.04.26

PBPK workflow for predicting clinical DDI risk of OATP1B1/3 inhibitors utilizing the CP-I biomarker: A case study with cyclosporine A

PBPK & PBBM

Pharmacometrics

Methodology

PBPK Conference 2026, Poster 23

Kanacher T, Pellowe M, Kovar C, Eriksson J, Wu J, Busse D, Gómez-Mantilla JD, Stopfer P, Ince I, Huang F

1 …345… 34

Related content

16cefda6ef73b7faa4df913b326b6999f7619968 (1)

Science & Services

b794ade33e3aa54f89dcdaa2b69d3f48b3f73e5f (1)

Latest news

4033665f49ccf946b5c8406d016bbcdc6e406076 (1)

People & Culture

Contact

Pharmetheus AB
Kungsängstull 4  
753 19 Uppsala, Sweden

Visiting address:  
Dragarbrunnsgatan 77, 5th floor

LinkedIn
YouTube

Science & Services
Quick links

About Pharmetheus

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.

Copyright © Pharmetheus AB 2026

Whistleblower
Privacy Policy
Cookie Policy